In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug
By BY REBECCA ROBBINS AND PAM BELLUCK fro Health Alzheimer's Disease, Labeling and Labels (Product), Aduhelm (Drug), Drugs (Pharmaceuticals), Clinical Trialsm NYT Health https://ift.tt/3wpL7KI
In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug
Reviewed by V. Kumar
on
July 08, 2021
Rating:
No comments: